Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 8/20 | 0.66 |
| ▸ | FFAR4 | Q5NUL3 | 3/20 | 0.66 |
| ▸ | LTA4H | P09960 | 1/20 | 0.63 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.63 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.56 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.54 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.54 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.54 |
| ▸ | BCHE | P06276 | 2/20 | 0.54 |
| ▸ | MGLL | Q99685 | 2/20 | 0.53 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7276062 | 0.91 | FFAR1 (0.74) | FFAR1FFAR4LTA4HEPHX2ALOX5 | |
| SCHEMBL19825762 | 0.90 | FFAR1 (0.61) | FFAR1FFAR4LTA4HEPHX2ALOX5 | |
| SCHEMBL14368556 | 0.89 | TDP1 (0.61) | ALOX5MGLL | |
| SCHEMBL31329294 | 0.87 | ALDH1A1 (0.61) | FFAR1ALOX5 | |
| SCHEMBL1860911 | 0.87 | FFAR1 (0.64) | FFAR1FFAR4LTA4HEPHX2ALOX5 | |
| SCHEMBL7905578 | 0.86 | FFAR1 (0.82) | FFAR1FFAR4LTA4HEPHX2ALOX5 | |
| SCHEMBL14793821 | 0.86 | TRPV1 (0.57) | ALOX5MGLLAKR1B1 | |
| SCHEMBL8890454 | 0.86 | FFAR1 (0.59) | FFAR1FFAR4LTA4HEPHX2ALOX5 | |
| SCHEMBL8350924 | 0.86 | CYP4F2 (0.60) | FFAR1FFAR4NR4A2BCHEMGLL | |
| SCHEMBL8888760 | 0.85 | FFAR1 (0.58) | FFAR1FFAR4LTA4HEPHX2ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6197975-B1 | 7-AZABICYCLO(2.2.1)HEPTANE-7-CARBONYL-SUBSTITUTED 2-PHENYLINDOLE DERIVATIVES; SEXUAL DISORDERS; ANTICARCINOGENIC AGENTS | MERCK & CO. , INC. | 2001-03-06 | — | — | US | disclosed |
| EP-0868178-A4 | ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE | MERCK & CO INC (US) | 2000-03-29 | — | — | EP | disclosed |
| EP-0882040-A4 | ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE | MERCK & CO INC (US) | 1999-02-10 | — | — | EP | disclosed |
| EP-0882040-A1 | ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE | Merck & Co., Inc. (US) | 1998-12-09 | — | — | EP | disclosed |
| EP-0868178-A1 | ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE | Merck & Co., Inc. (US) | 1998-10-07 | — | — | EP | disclosed |
| US-5756507-A | TREATING SEX HORMONE RELATED DISORDERS | MERCK & CO., INC. (US) | 1998-05-26 | — | — | US | disclosed |
| WO-1997021707-A1 | ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE | MERCK & CO., INC. (US) | 1997-06-19 | — | — | WO | disclosed |
| WO-1997021435-A1 | ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE | MERCK & CO., INC. (US) | 1997-06-19 | — | — | WO | disclosed |